HGF and ovarian carcinoma: Furthermore, it was proposed that circulating serum HGF (sHGF) levels are significantly raised in ovarian cancer patients at primary diagnosis compared with patients with borderline tumors or benign disease, and that elevated sHGF levels indicate poor prognosis [25].